Thinking Creatively About Treatment-Resistant Depression
The Carlat Psychiatry Report, Volume 14, Number 4, April 2016
J. Alexander Bodkin, MD
Director of the Clinical Psychopharmacology Research Program at McLean Hospital in Belmont, MA; assistant professor of psychiatry at Harvard Medical School
Dr. Bodkin has disclosed that he has been a principal investigator in a study of brexpiprazole. Dr. Carlat has reviewed his interview and has found no evidence of bias in this educational activity.
Dr. Bodkin discusses methods for approaching treatment resistant depression and his perspective on depressive illness as a final common pathway for a number of different brain problems.